FLAM
First Light Asset Management Portfolio holdings
AUM
$771M
This Quarter Return
-0.93%
1 Year Return
+33.17%
3 Year Return
+208.13%
5 Year Return
+426.73%
10 Year Return
+3,318.8%
AUM
$1.52B
AUM Growth
+$1.52B
(-8.9%)
Cap. Flow
-$67.3M
Cap. Flow
% of AUM
-4.44%
Top 10 Holdings %
Top 10 Hldgs %
43.87%
Holding
86
New
7
Increased
23
Reduced
23
Closed
3
Top Buys
| 1 |
BCYC
Bicycle Therapeutics
BCYC
|
$30.5M |
| 2 |
Ultragenyx Pharmaceutical
RARE
|
$19.1M |
| 3 |
PHLT
Performant Healthcare, Inc. Common Stock
PHLT
|
$17.6M |
| 4 |
SPDR S&P Biotech ETF
XBI
|
$15.3M |
| 5 |
BioMarin Pharmaceuticals
BMRN
|
$13.6M |
Top Sells
| 1 |
Arrowhead Research
ARWR
|
$38.6M |
| 2 |
Glaukos
GKOS
|
$34.7M |
| 3 |
Prothena Corp
PRTA
|
$34.1M |
| 4 |
Halozyme
HALO
|
$23.3M |
| 5 |
Genmab
GMAB
|
$15.2M |
Sector Composition
| 1 | Healthcare | 80.69% |
| 2 | Communication Services | 5.47% |
| 3 | Consumer Discretionary | 0.55% |
| 4 | Energy | 0.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
AbbVie
ABBV
$374B
| $403K | 0.03% |
3,740
| – | – |
|
77
Cigna
CI
$80.2B
| $389K | 0.03% |
1,943
| – | – |
|
78
Pfizer
PFE
$141B
| $364K | 0.02% |
8,469
| – | – |
|
79
Johnson & Johnson
JNJ
$429B
| $349K | 0.02% |
2,161
| – | – |
|
80
Sanofi
SNY
$122B
| $321K | 0.02% |
6,650
| – | – |
|
81
Universal Health Services
UHS
$11.6B
| $284K | 0.02% |
2,050
| – | – |
|
82
McKesson
MCK
$85.9B
| $268K | 0.02% |
1,346
| – | – |
|
83
Emergent Biosolutions
EBS
$418M
| $215K | 0.01% |
4,294
| – | – |
|
|
84
Glaukos
GKOS
$5.42B
| – | – |
-409,144
| Closed | -$34.7M |
|
85
Fate Therapeutics
FATE
$115M
| – | – |
-15,400
| Closed | -$1.34M |
|
|
86
Arrowhead Research
ARWR
$3.84B
| – | – |
-465,572
| Closed | -$38.6M |
|